We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.47B
AUM Growth
+$5.28M
Cap. Flow
+$84.4M
Cap. Flow %
1.54%
Top 10 Hldgs %
38.56%
Holding
3,811
New
262
Increased
1,518
Reduced
1,059
Closed
194
Avg Time Held Equity + Options
4.9 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
4.3 years
Avg Time Held Equity only
4.9 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
4.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.44%
2 Technology 18.26%
3 Financials 6.95%
4 Healthcare 6.81%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TASK icon
3301
TaskUs
TASK
$756M
$790 ﹤0.01%
67
– –
2022 Q4
12 quarters
APPS icon
3302
Digital Turbine
APPS
$1.2B
$785 ﹤0.01%
157
– –
2025 Q3
1 quarter
HMN icon
3303
Horace Mann Educators
HMN
$1.87B
$785 ﹤0.01%
17
– –
2021 Q1
19 quarters
SVV icon
3304
Savers
SVV
$1.54B
$785 ﹤0.01%
84
-150
-64% -$1.54K
2024 Q4
4 quarters
UNTY icon
3305
Unity Bancorp
UNTY
$572M
$776 ﹤0.01%
15
– –
2025 Q2
2 quarters
CMTG icon
3306
Claros Mortgage Trust
CMTG
$168M
$774 ﹤0.01%
253
– –
2024 Q4
4 quarters
NBBK icon
3307
NB Bancorp
NBBK
$973M
$773 ﹤0.01%
39
+19
+95% +$361
2024 Q4
4 quarters
NMAX icon
3308
Newsmax Inc
NMAX
$1.15B
$773 ﹤0.01%
100
– –
2025 Q2
2 quarters
CPRX icon
3309
DELISTED
Catalyst Pharmaceutical
CPRX
$770 ﹤0.01%
33
+20
+154% +$446
2022 Q3
13 quarters
VNDA icon
3310
Vanda Pharmaceuticals
VNDA
$246M
$767 ﹤0.01%
87
– –
2024 Q1
7 quarters
THM icon
3311
International Tower Hill Mines
THM
$560M
$766 ﹤0.01%
+412
New +$767
2025 Q4
0 quarters
EQBK icon
3312
Equity Bancshares
EQBK
$969M
$759 ﹤0.01%
17
-18
-51% -$770
2023 Q1
11 quarters
ARLO icon
3313
Arlo Technologies
ARLO
$1.3B
$755 ﹤0.01%
54
– –
2022 Q4
12 quarters
BZ icon
3314
Kanzhun
BZ
$7.27B
$754 ﹤0.01%
37
-1
-3% -$22
2025 Q1
3 quarters
LUNG icon
3315
Pulmonx
LUNG
$76M
$743 ﹤0.01%
336
– –
2021 Q2
18 quarters
BNTC icon
3316
Benitec Biopharma
BNTC
$284M
$741 ﹤0.01%
+55
New +$761
2025 Q4
0 quarters
NPKI icon
3317
NPK International
NPKI
$915M
$739 ﹤0.01%
62
– –
2025 Q2
2 quarters
SES icon
3318
SES AI
SES
$291M
$738 ﹤0.01%
410
– –
2025 Q2
2 quarters
LRMR icon
3319
Larimar Therapeutics
LRMR
$206M
$735 ﹤0.01%
+193
New +$751
2025 Q4
0 quarters
GRNT icon
3320
Granite Ridge Resources
GRNT
$714M
$729 ﹤0.01%
155
+78
+101% +$403
2024 Q3
5 quarters
BCRX icon
3321
BioCryst Pharmaceuticals
BCRX
$1.99B
$725 ﹤0.01%
93
-50
-35% -$361
2024 Q2
6 quarters
EGO icon
3322
Eldorado Gold
EGO
$9.39B
$718 ﹤0.01%
20
+9
+82% +$269
2022 Q1
15 quarters
PANL icon
3323
Pangaea Logistics
PANL
$499M
$709 ﹤0.01%
103
– –
2025 Q1
3 quarters
AVNS icon
3324
DELISTED
Avanos Medical
AVNS
$707 ﹤0.01%
63
-320
-84% -$3.66K
2016 Q4
36 quarters
SLDB icon
3325
Solid Biosciences
SLDB
$597M
$705 ﹤0.01%
125
– –
2022 Q1
15 quarters

Similar funds

Parallel Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Parallel Advisors held 3,811 positions worth $5.47B, up 0.1% from $5.46B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q4 2025 filing shows 262 new, 1,518 increased, 1,059 reduced and 194 closed positions. Its largest new stake was iShares iBonds Dec 2032 Term Treasury ETF: 66,034 shares worth $1.52M. The largest sale was PIMCO Ultra Short Government Active ETF, an estimated $6.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2025 buy was iShares iBonds Dec 2032 Term Treasury ETF: 66,034 shares worth $1.52M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $11M increase.
  • Parallel Advisors's biggest Q4 2025 reduction was PIMCO Ultra Short Government Active ETF, cutting an estimated $6.6M.
  • Parallel Advisors fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $5.01M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5.47B portfolio in Q4 2025.
  • Parallel Advisors opened 262 new positions and closed 194 in Q4 2025.
  • Parallel Advisors's portfolio value rose 0.1% quarter-over-quarter to $5.47B.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.